Elizabeth Allen
Postdoctoral Scientist
After completing my undergraduate degree in Biochemistry at the University of Southampton, I joined the Jenner Institute as a research assistant, working on the development of vaccines against Staphylococcus aureus. I then completed my DPhil in structural virology at Oxford University in the department of structural biology (Strubi). My research involved investigating the immune response to emerging phleboviruses.
At the Jenner Institute, I am currently working on the development of vaccines against Influenza and SARS-CoV-2, which involves generating new vaccine constructs and testing their immunogenicity in preclinical models.
Recent publications
-
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
Journal article
Spencer AJ. et al, (2021), Nature Communications, 12
-
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 Beta (B.1.351) and other variants of concern in preclinical studies
Journal article
Spencer AJ. et al, (2021)
-
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113
-
COVID-19 convalescent plasma: Interim recommendations from the AABB.
Journal article
Cohn CS. et al, (2021), Transfusion, 61, 1313 - 1323
-
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Journal article
Voysey M. et al, (2021), The Lancet, 397, 881 - 891